| Subject: | FDA Releases Draft Recommendations for the Assessment of Blood Donor Suitability, Blood Product Safety, and Preservation of the Blood Supply in Response to Pandemic (H1N1) |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Tue, 17 Nov 2009 - 12:00 pm |
| The Food and Drug Administration (FDA) has released draft recommendations for the assessment of blood donor suitability, blood product safety and the preservation of blood supply in response to the H1N1 pandemic. The draft guidance is intended for establishments that manufacture whole blood and blood components intended for use in transfusion and blood components intended for further manufacture, including recovered plasma, source plasma and source leukocytes. According to the FDA, due to... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|
